These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

276 related articles for article (PubMed ID: 34953856)

  • 1. Efficient incorporation and template-dependent polymerase inhibition are major determinants for the broad-spectrum antiviral activity of remdesivir.
    Gordon CJ; Lee HW; Tchesnokov EP; Perry JK; Feng JY; Bilello JP; Porter DP; Götte M
    J Biol Chem; 2022 Feb; 298(2):101529. PubMed ID: 34953856
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Remdesivir is a direct-acting antiviral that inhibits RNA-dependent RNA polymerase from severe acute respiratory syndrome coronavirus 2 with high potency.
    Gordon CJ; Tchesnokov EP; Woolner E; Perry JK; Feng JY; Porter DP; Götte M
    J Biol Chem; 2020 May; 295(20):6785-6797. PubMed ID: 32284326
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Template-dependent inhibition of coronavirus RNA-dependent RNA polymerase by remdesivir reveals a second mechanism of action.
    Tchesnokov EP; Gordon CJ; Woolner E; Kocinkova D; Perry JK; Feng JY; Porter DP; Götte M
    J Biol Chem; 2020 Nov; 295(47):16156-16165. PubMed ID: 32967965
    [TBL] [Abstract][Full Text] [Related]  

  • 4. The antiviral compound remdesivir potently inhibits RNA-dependent RNA polymerase from Middle East respiratory syndrome coronavirus.
    Gordon CJ; Tchesnokov EP; Feng JY; Porter DP; Götte M
    J Biol Chem; 2020 Apr; 295(15):4773-4779. PubMed ID: 32094225
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Mechanistic insight on the remdesivir binding to RNA-Dependent RNA polymerase (RdRp) of SARS-cov-2.
    Arba M; Wahyudi ST; Brunt DJ; Paradis N; Wu C
    Comput Biol Med; 2021 Feb; 129():104156. PubMed ID: 33260103
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Inhibition of SARS-CoV-2 polymerase by nucleotide analogs from a single-molecule perspective.
    Seifert M; Bera SC; van Nies P; Kirchdoerfer RN; Shannon A; Le TT; Meng X; Xia H; Wood JM; Harris LD; Papini FS; Arnold JJ; Almo S; Grove TL; Shi PY; Xiang Y; Canard B; Depken M; Cameron CE; Dulin D
    Elife; 2021 Oct; 10():. PubMed ID: 34617885
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Remdesivir overcomes the S861 roadblock in SARS-CoV-2 polymerase elongation complex.
    Wu J; Wang H; Liu Q; Li R; Gao Y; Fang X; Zhong Y; Wang M; Wang Q; Rao Z; Gong P
    Cell Rep; 2021 Oct; 37(4):109882. PubMed ID: 34653416
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Structural basis for inhibition of the RNA-dependent RNA polymerase from SARS-CoV-2 by remdesivir.
    Yin W; Mao C; Luan X; Shen DD; Shen Q; Su H; Wang X; Zhou F; Zhao W; Gao M; Chang S; Xie YC; Tian G; Jiang HW; Tao SC; Shen J; Jiang Y; Jiang H; Xu Y; Zhang S; Zhang Y; Xu HE
    Science; 2020 Jun; 368(6498):1499-1504. PubMed ID: 32358203
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Broad spectrum antiviral remdesivir inhibits human endemic and zoonotic deltacoronaviruses with a highly divergent RNA dependent RNA polymerase.
    Brown AJ; Won JJ; Graham RL; Dinnon KH; Sims AC; Feng JY; Cihlar T; Denison MR; Baric RS; Sheahan TP
    Antiviral Res; 2019 Sep; 169():104541. PubMed ID: 31233808
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Sofosbuvir terminated RNA is more resistant to SARS-CoV-2 proofreader than RNA terminated by Remdesivir.
    Jockusch S; Tao C; Li X; Chien M; Kumar S; Morozova I; Kalachikov S; Russo JJ; Ju J
    Sci Rep; 2020 Oct; 10(1):16577. PubMed ID: 33024223
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Synthesis and antiviral activity of fatty acyl conjugates of remdesivir against severe acute respiratory syndrome coronavirus 2 and Ebola virus.
    El-Sayed NS; Jureka AS; Edwards MR; Lohan S; Williams CG; Keiser PT; Davey RA; Totonchy J; Tiwari RK; Basler CF; Parang K
    Eur J Med Chem; 2021 Dec; 226():113862. PubMed ID: 34583312
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Off-Target
    Xu Y; Barauskas O; Kim C; Babusis D; Murakami E; Kornyeyev D; Lee G; Stepan G; Perron M; Bannister R; Schultz BE; Sakowicz R; Porter D; Cihlar T; Feng JY
    Antimicrob Agents Chemother; 2021 Jan; 65(2):. PubMed ID: 33229429
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Remdesivir and SARS-CoV-2: Structural requirements at both nsp12 RdRp and nsp14 Exonuclease active-sites.
    Shannon A; Le NT; Selisko B; Eydoux C; Alvarez K; Guillemot JC; Decroly E; Peersen O; Ferron F; Canard B
    Antiviral Res; 2020 Jun; 178():104793. PubMed ID: 32283108
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Mutations in the SARS-CoV-2 RNA-dependent RNA polymerase confer resistance to remdesivir by distinct mechanisms.
    Stevens LJ; Pruijssers AJ; Lee HW; Gordon CJ; Tchesnokov EP; Gribble J; George AS; Hughes TM; Lu X; Li J; Perry JK; Porter DP; Cihlar T; Sheahan TP; Baric RS; Götte M; Denison MR
    Sci Transl Med; 2022 Aug; 14(656):eabo0718. PubMed ID: 35482820
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Development of a Simple
    Lu G; Zhang X; Zheng W; Sun J; Hua L; Xu L; Chu XJ; Ding S; Xiong W
    Antimicrob Agents Chemother; 2020 Dec; 65(1):. PubMed ID: 33122171
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Mechanism of Inhibition of Ebola Virus RNA-Dependent RNA Polymerase by Remdesivir.
    Tchesnokov EP; Feng JY; Porter DP; Götte M
    Viruses; 2019 Apr; 11(4):. PubMed ID: 30987343
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Genetic conservation of SARS-CoV-2 RNA replication complex in globally circulating isolates and recently emerged variants from humans and minks suggests minimal pre-existing resistance to remdesivir.
    Martin R; Li J; Parvangada A; Perry J; Cihlar T; Mo H; Porter D; Svarovskaia E
    Antiviral Res; 2021 Apr; 188():105033. PubMed ID: 33549572
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Mechanism of SARS-CoV-2 polymerase stalling by remdesivir.
    Kokic G; Hillen HS; Tegunov D; Dienemann C; Seitz F; Schmitzova J; Farnung L; Siewert A; Höbartner C; Cramer P
    Nat Commun; 2021 Jan; 12(1):279. PubMed ID: 33436624
    [TBL] [Abstract][Full Text] [Related]  

  • 19. RNA-dependent RNA polymerase: Structure, mechanism, and drug discovery for COVID-19.
    Jiang Y; Yin W; Xu HE
    Biochem Biophys Res Commun; 2021 Jan; 538():47-53. PubMed ID: 32943188
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Remdesivir targets a structurally analogous region of the Ebola virus and SARS-CoV-2 polymerases.
    Lo MK; Albariño CG; Perry JK; Chang S; Tchesnokov EP; Guerrero L; Chakrabarti A; Shrivastava-Ranjan P; Chatterjee P; McMullan LK; Martin R; Jordan R; Götte M; Montgomery JM; Nichol ST; Flint M; Porter D; Spiropoulou CF
    Proc Natl Acad Sci U S A; 2020 Oct; 117(43):26946-26954. PubMed ID: 33028676
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 14.